A Clinically Applicable 24-Protein Model for Classifying Risk Subgroups in Pancreatic Ductal Adenocarcinomas using Multiple Reaction Monitoring-Mass Spectrometry
- Clin. Cancer Res., Published first February 16, 2021 | DOI: 10.1158/1078-0432.CCR-20-3513
